Synmosa Biopharma PEG Ratio

Synmosa Biopharma (4114.TWO) currently reports a PEG ratio of 196.73. That is above the sector sector average of 9.98. Use the charts on this page to explore Synmosa Biopharma's PEG ratio history and peer comparisons.

Synmosa Biopharma's PEG ratio of 196.73 is higher than the its sector sector average of 9.98. That is roughly 1870.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Synmosa Biopharma's market price to a fundamental measure such as earnings, sales, or book value. At 196.73, 4114.TWO can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 196.73, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 9.98. From there, open related valuation or income-statement pages for Synmosa Biopharma, and consider following 4114.TWO for alerts when major investors trade the stock.